Literature DB >> 9892677

Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns.

M Yoshioka1, P M Vacek, T Poseno, R Silver, B A Finette.   

Abstract

Limited information is available regarding the frequency, spectrum, and clinical relevance of somatic mutations in the developing fetus. The goal of this study was to determine somatic mutant frequencies (Mfs) at the hypoxanthine phosphoribosyltransferase (HPRT) reporter gene in cord blood T lymphocytes from preterm infants to gain insight into in utero mutational events. Mf determinations were made by using the HPRT T cell cloning assay on cord blood samples from 52 preterm infants. Natural logarithm Mfs (lnMfs) from preterm infants were compared with results from our database for full-term infants. Our analysis revealed higher lnMfs in cord blood T lymphocytes from preterm compared with full-term infants (P = 0.008). In addition, preterm females had significantly higher lnMfs compared with full-term females (P < 0.001), whereas preterm males were found to have significantly lower lnMfs than preterm females (P = 0.005). Regression analyses also demonstrate a significant relationship between lnMf and gestational age for preterm females that does not exist for preterm males. These results demonstrate the gender-specific association between Mf and age in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9892677      PMCID: PMC15180          DOI: 10.1073/pnas.96.2.586

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Dependence of bone marrow cells on the liver for purine supply.

Authors:  L G LAJTHA; J R VANE
Journal:  Nature       Date:  1958-07-19       Impact factor: 49.962

Review 2.  Developmental and maturational changes in human blood lymphocyte subpopulations.

Authors:  I Hannet; F Erkeller-Yuksel; P Lydyard; V Deneys; M DeBruyère
Journal:  Immunol Today       Date:  1992-06

3.  Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans.

Authors:  J P O'Neill; M J McGinniss; J K Berman; L M Sullivan; J A Nicklas; R J Albertini
Journal:  Mutagenesis       Date:  1987-03       Impact factor: 3.000

4.  Mosaicism of peripheral blood lymphocyte populations in females heterozygous for the Lesch-Nyhan mutation.

Authors:  R J Albertini; R DeMars
Journal:  Biochem Genet       Date:  1974-05       Impact factor: 1.890

5.  T cells responsive to myelin basic protein in patients with multiple sclerosis.

Authors:  M Allegretta; J A Nicklas; S Sriram; R J Albertini
Journal:  Science       Date:  1990-02-09       Impact factor: 47.728

6.  Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity.

Authors:  P D Aplan; D P Lombardi; A M Ginsberg; J Cossman; V L Bertness; I R Kirsch
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

7.  Observations on the growth in vitro of myeloid progenitor cells and fibroblasts from hemizygotes and heterozygotes for "complete" and "partial" hypoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency, and their relevance to the pathogenesis of brain damage in the Lesch-Nyhan syndrome.

Authors:  R O McKeran; A Howell; T M Andrews; R W Watts; C F Arlett
Journal:  J Neurol Sci       Date:  1974-06       Impact factor: 3.181

8.  Detection of the carrier state for an X-linked disorder, the Lesch-Nyhan syndrome, by the use of lymphocyte cloning.

Authors:  J L Dempsey; A A Morley; R S Seshadri; B T Emmerson; R Gordon; C I Bhagat
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  A new method for the detection of Lesch-Nyhan heterozygotes by peripheral blood T cell culture using T cell growth factor.

Authors:  N Kamatani; H Yamanaka; K Nishioka; T Nakamura; K Nakano; K Tanimoto; T Mizuno; Y Nishida
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

10.  The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase.

Authors:  Y Gu; G Cimino; H Alder; T Nakamura; R Prasad; O Canaani; D T Moir; C Jones; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  1 in total

1.  Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease.

Authors:  Truc Nguyen; Pamela M Vacek; Patrick O'Neill; Richard B Colletti; Barry A Finette
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.